PAA 1.04% 24.3¢ pharmaust limited

Pfizer

  1. 1,516 Posts.
    lightbulb Created with Sketch. 630
    Does Pfizer's CoVid-19 vaccination strong hopeful with early data signals strengthen or weaken the company's development of a vaccine also? It is a huge job vaccinating the globe in due course and I would not be alone in saying that that there would be room for other branding hopefuls who have capabilities of becoming successful under the right circumstances. Remember Kalkine Media reported that both MPL and MPLS treatments reduces up to approx 95% CoV-2 virus particles in cell culture.

    PAA is a minnow with many strings to its bow in the environment of multi billion dollar parmaceuticals and would would become a highly priced share in any successful development and manufacturing happening.
    Their cancer research is also outstanding. Don't give up on them. Dyor.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
24.3¢
Change
0.003(1.04%)
Mkt cap ! $94.80M
Open High Low Value Volume
24.0¢ 24.5¢ 24.0¢ $20.29K 84.48K

Buyers (Bids)

No. Vol. Price($)
6 62896 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 23496 4
View Market Depth
Last trade - 11.55am 29/04/2024 (20 minute delay) ?
Last
24.0¢
  Change
0.003 ( 0.67 %)
Open High Low Volume
24.5¢ 24.5¢ 24.0¢ 44267
Last updated 12.27pm 29/04/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.